EGFR and glioblastoma: Regarding MES transition, a hallmark of GBM, it was shown that FOXM1 binding to A Disintegrin And Mettaloproteinase 17 (ADAM17) promoter upregulates its expression and maintains the ADAM17/EGFR feedback loop that promotes mesenchymal transition in GBM [109].